My Companies
Notification
Account
Log Out
Back

Alembic Partner Natco Receives USFDA Tentative Approval For $1.4 B Olaparib

18 July 2026
Alembic Pharmaceuticals Ltd.

Alembic's partner NATCO received USFDA tentative approval for Olaparib Tablets, generic Lynparza (market ~USD 1.4bn). Para IV litigation continues. Cumulative ANDA approvals at 244 (20 tentative).

Recent Events

19 June 2026

Alembic Pharma Gets USFDA Tentative Nod for $259 M Binimetinib Tablets
11 June 2026

Alembic Pharma Receives USFDA Tentative Approval for Larotrectinib Capsules

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information